In vivo, we demonstrate in both this clinically relevant murine model and in human breast cancers that DEK expressing tumors regulate a similar pattern of immunomodulatory genes identified in our ex vivo cell culture model and contain CD163+ M2-like TAMs. Here, CD163 is linked to breast carcinoma.